17
Supplem demethyla Reactions Supplem demethyla Reactions mentary Fig ation of the s containing mentary Fig ation of th s containing gure 1 KDM e shown v g enzyme a gure 2 PHF he shown v g enzyme a M2A cataly ariant histo re in red wi F8 catalys variant hist re in red wi yses only l one peptide th peptide o es only ly tone peptid th peptide o ysine dem es as catal only control ysine deme des as cata only control methylation. ysed by re s in black. ethylation. alysed by s in black. . MALDI-TO ecombinant MALDI-TO recombina OF MS of KDM2A. OF MS of nt PHF8.

KDM - media.nature.com · istone pep d with pep eptides. tides as tide only . Supplem MALDI-TO by recom black. entary Fig F MS of d binant KDM ure 10 K emethylati 3A. React DM3A doe

Embed Size (px)

Citation preview

SupplemdemethylaReactions

SupplemdemethylaReactions

mentary Figation of thes containing

mentary Figation of ths containing

gure 1 KDMe shown vg enzyme a

gure 2 PHFhe shown vg enzyme a

M2A catalyariant histore in red wi

F8 catalysvariant histre in red wi

yses only lone peptideth peptide o

es only lytone peptidth peptide o

ysine demes as catalonly control

ysine demedes as cataonly control

methylation.ysed by res in black.

ethylation. alysed by s in black.

. MALDI-TOecombinant

MALDI-TOrecombina

OF MS of KDM2A.

OF MS of nt PHF8.

SupplemMS of deKDM3A. text for ot

SupplemMS of deKDM4E. text for ot

mentary FigemethylatioReactions cther KDM3A

mentary FigemethylatioReactions cther KDM4E

ure 3 KDMon of the scontaining eA assays (F

ure 4 KDMon of the scontaining eE assays (F

M3A catalysshown varienzyme are

Fig. 2b).

M4E catalysshown varienzyme are

Fig. 2b).

ses lysine aant histonee in red with

ses lysine aant histonee in red with

and arginine peptides h peptide o

and arginine peptides h peptide o

ne demethyas catalys

only controls

ne demethyas catalys

only controls

ylation. MAsed by recs in black. S

ylation. MAsed by recs in black. S

ALDI-TOF combinant See main

ALDI-TOF combinant See main

SupplemMS of deKDM5C. text for ot

SupplemMS of deKDM6B.

mentary FigemethylatioReactions cther KDM5C

mentary FigemethylatioReactions

ure 5 KDMon of the scontaining eC assays (F

ure 6 KDMon of the s

containing

M5C catalysshown varienzyme are

Fig. 2b).

M6B catalysshown vari enzyme a

ses lysine aant histonee in red wit

ses lysine aant histoneare in red

and arginine peptides h peptide o

and arginine peptides

with pepti

ne demethyas catalys

only controls

ne demethyas catalys

de only co

ylation. MAsed by recs in black. S

ylation. MAsed by recontrols in b

ALDI-TOF combinant See main

ALDI-TOF combinant black. (a)

reactions reaction w

SupplemNMR spe(residuesand the aare highH3K27Rmcorresponhighlighteshowing KDM6B-csequence

with 15mwith 21mer

mentary Figectrum of 18-32, se

arginine methlighted. (bme2a peptinding to theed. The formtime-depen

catalysed de KAPRKQL

er argininepeptide. Se

ure 7 NMRKDM6B-ca

equence KQthyl groups

b) 1H-13C-Hide (residue methyl gromaldehyde ndent formademethylatioLATKAARR

e methylateee main text

R analysis oatalysed deQLATKAARof substrate

HSQC spees 18-32, oup of Nω-mscavenger

ation of Non of a 2

Rme2aSAPA

ed-peptidest for other K

of KDM6B emethylationRRme2aSAPe and mono

ectrum of sequence

monomomer dimedone

Nω-monomom21 residueATGG).

(16mer lyKDM6B ass

catalysed an of a 15 PAT). 1H-reomethylatedKDM6B-caKQLATKA

thylarginine is presentmethylarginH3K27Rm

ysine methyays (Fig. 2b

arginine deresidue H

esonances d product peatalysed deAARRme2aSe (δH 2.76 pt in the samnine and sue2a peptid

ylated-peptb).

emethylatioH3K27me2a

for 2OG, eptide (δH 2emethylatioSAPAT). T

ppm, δC 27.mple. (c) 1Huccinate d

de (residue

tide) (b)

on. (a) 1H a peptide succinate

2.76 ppm) n of an

The peak 5 ppm) is H spectra uring the

es 14-34,

SupplemMALDI-TOcatalysedcontrols in

mentary FigOF MS of

d by recombn black See

gure 8 KDMf demethylabinant KDMe main text f

M4E catalyation of thM4E. Reactfor other as

yses argine shown ations contaissays (Fig. 4

ine demetharginine mening enzym4a).

hylation inethylated h

me are in re

n histone phistone peped with pep

peptides. ptides as ptide only

SupplemMALDI-TOcatalysedcontrols in

mentary FigOF MS of

d by recombn black See

gure 9 KDMf demethylabinant KDMe main text f

M5C catalyation of thM5C. Reactfor other as

yses argine shown ations contaissays (Fig. 4

ine demetharginine mening enzym4b).

hylation inethylated h

me are in re

n histone phistone peped with pep

peptides. ptides as ptide only

SupplemMALDI-TOby recomblack.

mentary FigOF MS of d

mbinant KDM

gure 10 KdemethylatiM3A. React

DM3A doeon of the stions contai

es not cathown arginining enzym

talyse histine methyla

me are in re

tone arginated histoneed with pep

ine demete peptides ptide only c

thylation. catalysed

controls in

SupplemMALDI-TOby recomblack.

mentary FigOF MS of d

mbinant KDM

gure 11 KdemethylatiM6B. React

DM6B doeon of the stions contai

es not cathown arginining enzym

talyse histine methyla

me are in re

tone arginated histoneed with pep

ine demete peptides ptide only c

thylation. catalysed

controls in

Supplemblot analyKDMs webead demdetected

SupplemMALDI-TOKDM3A impeptide o

mentary Figysis of HEKere immunomethylationusing anti-F

mentary FigOF MS of mmunoprecnly controls

gure 12 OveK293T cell precipitated assays (F

Flag primary

ure 13 Fulldemethylat

cipitated fros in black. S

erexpressiolysates exo

d using antiFig. 5, Supy antibody (

l length KDtion of the om HEK293See main tex

on of full logenously -flag beadspplementary(for source

DM3A catalshown his

3T cells. Rext for other

length KDMexpressing

s to producey Fig. 13-1see Method

lyses argintone peptid

eactions conassays (Fig

Ms in HEK2full length

e full length 16). Full leds).

nine and lysdes as catantaining enzg. 5).

293T cells.Flag-taggeKDMs for u

ength prote

ysine demealysed by fzyme are in

. Western ed KDMs. use in on-eins were

thylation. full length n red with

SupplemMALDI-TOKDM4A impeptide o

mentary FigOF MS of mmunoprecnly controls

ure 14 Fulldemethylat

cipitated fros in black. S

l length KDtion of the om HEK293See main tex

DM4A catalshown his

3T cells. Rext for other

lyses argintone peptid

eactions conassays (Fig

nine and lysdes as catantaining enzg. 5).

ysine demealysed by fzyme are in

thylation.

full length n red with

SupplemMALDI-TOKDM5C ipeptide o

SupplemMALDI-TOKDM6B impeptide o

mentary FigOF MS of mmunoprecnly controls

mentary FigOF MS of mmunoprecnly controls

ure 15 Fulldemethylat

cipitated fros in black. S

ure 16 Fulldemethylat

cipitated fros in black. S

l length KDtion of the om HEK293See main tex

l length KDtion of the om HEK293See main tex

DM5C catalshown his

3T cells. Rext for other

DM6B catalshown his

3T cells. Rext for other

lyses argintone peptid

eactions conassays (Fig

lyses argintone peptid

eactions conassays (Fig

nine and lysdes as catantaining enzg. 5).

nine and lysdes as catantaining enzg. 5).

ysine demealysed by fzyme are in

ysine demealysed by fzyme are in

thylation. full length n red with

thylation. full length n red with

SupplemMALDI-TOrecombinpeptide o

mentary FigOF MS ofant KDM5Cnly controls

ure 17 KDMf demethylC, KDM4Es in black.

Ms catalyslation of t, and KDM

e arginine he shown

M6B. React

demethylanon-histon

tions conta

ation in nonne peptideaining enzy

n-histone pes as catayme are in

peptides. alysed by

red with

Supplem

Stereovie

peptide re

asymmet

electron

indicating

suggested

KDM4A c

structure.

unproduc

conforma

the metal

Compare

chain wa

account fo

mentary Fig

ew from PD

esidues. KD

ric unit KDM

density wa

g lower occ

d binding o

chains A an

In KDM4

ctive since b

ations were

l to enable

d to methy

as observed

or their cata

ure 18 Ste

B 5FWE sh

DM4A.Ni.N

M4A (chains

as observed

cupancy (<1

of more tha

nd B; only t

A Chain A

both N-meth

refined in b

catalysis (w

ylated-lysine

d to adopt

alytic differe

reoview fro

howing the F

OG.H4R3m

s A and B).

d for resid

1.00) for su

an one con

the major c

A, the met

hyl groups a

both of whi

within 4.2 Å

e structures

more than

ences (Fig 6

om a KDM4

Fo-Fc OMIT

me2s comp

In both KD

ues in the

ubstrate re

nformations

conformatio

thylated arg

are too far f

ich one of t

Å) (b) as ob

s, it is of int

n one diffe

6).

4A.Ni.NOG

T map cont

lex crystalli

DM4A chains

H4R3me2

sidues. Th

of the me

ons were m

ginine conf

from the me

the N-meth

bserved for

terest that

rent extend

G.H4R3me2

toured to 3

ised with tw

s A and B, o

2s peptides

is unweight

thylated arg

odelled and

formation is

etal (>6.0 Å

yl groups w

N-methyl ly

the N-meth

ded conform

2s crystal s

around H4

wo molecul

only weak d

s (chains C

ted Fo-Fc O

rginine side

d refined in

s likely ca

Å) (a) In cha

was close e

ysine substr

hylated argi

mations, w

structure.

4R3me2s

es of per

difference

C and D)

OMIT map

echains in

n the final

atalytically

ain B, two

enough to

rates1, 2, 3.

nine side

hich may

Supplementary Table 1 Peptide sequences used in the biochemical assays. All peptides were prepared as C-terminal amides. In some cases small shifts from these masses are observed in the MS due to shifts in the calibration. In all cases demethylation is observed as a shift of 14 Da from the substrate peak. Histone Mark Amino Acid Sequence Monoisotopic

Mass / Da Enzyme for which activity is characterised

H3K4me3 ART-Kme3-QTARKSTGGKA 1602 KDM5C H3K4Rme2a ART-Rme2a-QTARKSTGGKA 1615 H3K4Rme2s ART-Rme2s-QTARKSTGGKA 1615 H3K4Rme ART-Rme-QTARKSTGGKA 1601 H3K9me3 ARTKQTAR-Kme3-STGGKA 1602 KDM4A/E H3K9me2 ARTKQTAR-Kme2-STGGKA 1587 KDM3A H3K9Rme2a ARTKQTAR-Rme2a-STGGKA 1615 H3K9Rme2s ARTKQTAR-Rme2s-STGGKA 1615 H3K9Rme ARTKQTAR-Rme-STGGKA 1601 H3K4me3K9me2 ART-Kme3-QTAR-Kme2-STGGKA 1631 KDM7B H3K4me3K9Rme2a ART-Kme3-QTAR-Rme2a-STGGKA 1658 H3K4me3K9Rme2s ART-Kme3-QTAR-Rme2s-STGGKA 1658 H3K4me3K9Rme ART-Kme3-QTAR-Rme-STGGKA 1644 H3K27me3 KQLATKAAR-Kme3-SAPSTG 1656 KDM6B H3K27Rme2a KQLATKAAR-Rme2a-SAPAT 1596 H3K27Rme2s KQLATKAAR-Rme2s-SAPAT 1596 H3K27Rme KQLATKAAR-Rme-SAPAT 1582 H3K27me3 (21mer) KAPRKQLATKAAR-Kme3-

SAPATGG 2150 KDM6B

H3K27Rme2a (21mer)

KAPRKQLATKAAR-Rme2a-SAPATGG

2163

H3K36me2 APATGGV-Kme2-KPHRYRP 1661 KDM2A H3K36Rme2a APATGGV-Rme2a-KPHRYRP 1689 H3K36Rme2s APATGGV-Rme2s-KPHRYRP 1689 H3K36Rme APATGGV-Rme-KPHRYRP 1675 H3R2me2a A-Rme2a-TKQTARKSTGGKA 1587 H3R2me2s A-Rme2a-TKQTARKSTGGKA 1587 H3R2me A-Rme-TKQTARKSTGGKA 1573 H3R2Kme3 A-Kme3-TKQTARKSTGGKA 1575 H3R8me2a ARTKQTA-Rme2a-KSTGGKA 1587 H3R8me2s ARTKQTA-Rme2s-KSTGGKA 1587 H3R8me ARTKQTA-Rme-KSTGGKA 1573 H3R17me2a STGGKAP-Rme2a-KQLATKA 1540 H3R17me2s STGGKAP-Rme2a-KQLATKA 1540 H3R17me STGGKAP-Rme-KQLATKA 1526 H3R26me2a KQLATKAA-Rme2a-KSAPAT 1568 H3R26me2s KQLATKAA-Rme2a-KSAPAT 1568 H3R26me KQLATKAA-Rme-KSAPAT 1554 H4R3me2a (15mer) SG-Rme2a-GKGGKGLGKGGA 1314 H4R3me2s (15mer) SG-Rme2s-GKGGKGLGKGGA 1314 H4R3me2a (16mer) SG-Rme2a-GKGGKGLGKGGAK 1441 H4R3me2s (16mer) SG-Rme2s-GKGGKGLGKGGAK 1441 H4R3me SG-Rme-GKGGKGLGKGGAK 1427 53BP1(1394-1415) R1401me2a

GKAPVTP-Rme2a-GRGRRGRPPSRTTG

2345

53BP1(1394-1415) R1403me2a

GKAPVTPRG-Rme2a-GRRGRPPSRTTG

2345

53BP1(1394-1415) R1405me2a

GKAPVTPRGRG-Rme2a-RGRPPSRTTG

2345

BRCA1(605-619)R610me2a

APKKN-Rme2a-LRRKSSTRH 1862

hnRNPK(295-309)R296me2a

G-Rme2a-GGRGGSRARNLPL 1550

hnRNPK(295-309)R299me2a

GRGG-Rme2a-GGSRARNLPL 1550

FMR1(537-551)R544me2a

GGRGQGG-Rme2a-GRGGGFK 1430

FMR1(537-551)R546me2a

GGRGQGGRG-Rme2a-GGGFK 1430

p53(332-343)R333me2s

IRGRE-Rme2s-FEMFRE 1652

p53(328-339)R335me2s

FTLQI-Rme2s-GRERFE 1578

p53(330-341)R336me2s

LQIRG-Rme2s-ERFEMF 1608

Supplementary Table 2 Assay conditions with truncated recombinant protein.

Enzyme [2OG] / µM [Ascorbate] / µM [FeII] / µM Buffer Conditions

KDM2A 100 100 10 50 mM HEPES pH 7.5

KDM3A 100 100 50 50 mM HEPES pH 7.5

KDM4E 200 100 10 50 mM HEPES pH 7.5

KDM5C 100 100 10 50 mM HEPES pH 7.5

KDM6B 100 100 10 50 mM HEPES pH 7.5, 150 mM NaCl

PHF8 100 100 10 100 mM HEPES pH 7.5, 500 mM NaCl

Supplementary Table 3 Assay conditions with full length Flag-tagged KDMs.

Enzyme [2OG] / mM [Ascorbate] / mM [FeII] / µM Buffer Conditions

KDM3A 1 1 50 50 mM HEPES pH 7.5

KDM4A 1 1 50 50 mM HEPES pH 7.5

KDM5C 1 1 50 50 mM HEPES pH 7.5

KDM6B 1 1 50 50 mM HEPES pH 7.5, 150 mM NaCl

Supplementary Table 4. Crystallographic data processing and refinement statistics

PDB acquisition code  5FWE    Data Collection   Beamline (Wavelength, Å)  I04‐1 (0.91741) Detector  Pilatus 2M Data processing  HKL20004 Space Group  P21212 Cell dimensions a,b,c (Å)  

100.739 149.400 57.372 

No. of molecules/ ASU  2 Resolution (Å)  49.85 – 2.05 (2.12 – 2.05)* Completeness (%)  99.7 (99.8)* Redundancy  7.9 (8.1)* Rsym**  0.1 (1.0)* 

Mean I/(I)  22.4 (2.5)* 

Wilson B value (Å2)  33.8    Refinement   Rwork / Rfree  0.234 / 0.256 No.reflections 54928(5334)*No.atoms ‐Enzyme(A/B) 2881/2850‐Metal(A/B) 2/2‐Ligand(A/B) 10/10‐Peptide(C/D) 17/29‐Water 392B‐factors ‐Enzyme(A/B) 47.9/47.5‐Metal(A/B) 32.8/30.4‐Ligand(A/B) 28.5/33.4‐Peptide(C/D) 73.3/74.1‐Water 45.9R.m.s. deviation     Bond length, Å  0.007 

  Bond angle,   1.069 

   One crystal was used for structure determination.*Highest resolution shell shown in parenthesis. Polypeptide chain in parenthesis.

Supplementary References 1 Couture JF, Collazo E, Ortiz-Tello PA, Brunzelle JS, Trievel RC. Specificity and

mechanism of JMJD2A, a trimethyllysine-specific histone demethylase. Nature Structural and Molecular Biology 14, 689-695 (2007).

2 Chen Z, et al. Structural basis of the recognition of a methylated histone tail by JMJD2A.

Proc Natl Acad Sci U S A 104, 10818-10823 (2007).

3 Ng SS, et al. Crystal structures of histone demethylase JMJD2A reveal basis for

substrate specificity. Nature 448, 87-91 (2007). 4 Otwinowski, Z., Minor, W. Processing of X-ray Diffraction Data Collected in Oscillation

Mode. Methods in Enzymology 276, 307-326 (1997).